Following recent advances in genetic engineering, development of new pharmaceutical products for the treatment of various diseases, previously difficult to treat, has been carried out.  Research and development are active across the world about the promising next-generation drugs such as those making use of nucleic acid (nucleic acid drucs) for gene expression regulation (antisense, decoy, siRNA, etc.), inhibition of the function for specific target molecules withaptamers, and so on.

We will continue our efforts for development of nucleic acid-based new-generation medicines and diagnostic reagents, with a goal set at becoming an enterprise contributing to human welfare and health through nucleic acid technology development.

GeneDesign, Inc.